Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex

Brain Research

Volumn 778, Issue 2, 1997, Pages 381-387

  Pelton, Gregory H ^a   Lee, Younglim ^a   Davis, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acoustic startle reflex; Corticotropin; Sensitization; Stress; Vasopressin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; MALE; MENTAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SENSITIZATION; STARTLE REFLEX; STRESS;

ACOUSTIC STIMULATION; ANIMALS; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; INJECTIONS, INTRAVENTRICULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; STARTLE REACTION; STRESS;

EID: 0031578767     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00669-0     Document Type: Article

References (61)

1. Abood L.G., Knapp R., Mitchell T., Booth H., Schwab L. Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J. Neurosci. Res. 5:1980;191-199.
2. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15:1994;321-350.
3. S.M. Antelman, Stressor-induced sensitization to subsequent stress: implications for the development and treatment of clinical disorders, in: P.W. Kalivas, C.D. Barnes (Eds.), Sensitization of the Nervous System, Telford Press, Caldwell, NJ, 1988, pp. 227-256.
4. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
5. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 14(2):1993;76-122.
6. Brinton R.E. Neuromodulation: associative and nonlinear adaptation. Brain Res. Bull. 24:1990;651-658.
7. Brinton R.E., McEwen B.S. Vasopressin neuromodulation in the hippocampus. J. Neurosci. 9(3):1989;752-759.
8. G.W. Brown, T.O. Harris, Depression, in: G.W. Brown, T.O. Harris (Eds.), Life Events and Illness, Guildford Press, New York, 1989, pp. 49-93.
9. Cassella J.V., Davis M. The design and calibration of a startle measurement system. Physiol. Behav. 36:1986;377-383.
10. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6:1986;2908-2914.
11. 1a receptor antagonist on cellular, autonomic and endocrine responses to repeated stress. Neuroscience. 64:1995;687-697.
12. M. Davis, The role of the amygdala in conditioned fear, in: The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, 1992, pp. 255-305.
13. Davis M., Falls W.A., Campeau S., Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav. Brain Res. 58:1993;175-198.
14. De Geoij D.C., Binnekade R., Tilders F.J. Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am. J. Physiol. 263:1992;E394-E399.
15. De Geoij D.C., Dijkstra H., Tilders F.S. Chronic psychosocial stress enhances vasopressin but not corticotropin-releasing factor, in the external zone of the eminence of male rats: relationship to subordinate status. Endocrinology. 131:1992;847-853.
16. De Geoij D.C., Jezova D., Tilders F.J. Repeated stress enhances vasopressin synthesis in corticotropin-releasing factor neurons in the paraventricular nucleus. Brain Res. 577:1992;165-168.
17. De Geoij D.C., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., Tilders F.J. Repeated stress-induced activation of corticotropin-releasing factor neurones enhances vasopressin stores and cocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology. 53:1991;150-159.
18. D. De Wied, M. Joels, J.P.H. Burbach, W. De Jong, E.R. de Kloet, O.W.J. Gaffori, I.J.A. Urban, J.M. van Ree, T.B. Van Wimersma Greidanus, H.D. Veldhuis, D.H.G. Versteeg, V.M. Wiegant, Vasopressin effects on central nervous system, in: A. Négro-Vilar, P.M. Conn (Eds.), Peptide Hormones: Effects and Mechanisms of Action, Vol. 1, CRC, Boca Raton, FL, 1988, pp. 97-140.
19. Demotes-Mainard J., Chauveau J., Rodriguez F., Vincent J.D., Poulain D.A. Septal release of vasopressin in response to osmotic, hypovolemic and electrical stimulation in rats. Brain Res. 381:1986;314-321.
20. DeSouza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. J. Neurosci. 7:1987;88-100.
21. Diamant M., De Wied D. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats. Am. J. Physiol. 264:1993;R51-R61.
22. Dunn A., Berridge C. Physiological and behavioral responses to corticotropin-releasing factor administration:is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
23. Elkabir D.R., Wyatt M.E., Vellucci S.V., Herbert J. The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Reg. Pept. 28:1990;199-214.
24. Freund-Mercier M.J., Stoeckel M.E., Dietl M.M., Palacios J.M., Richard P. Quantitative autoradiographic mapping of neurohypophysial hormone binding sites in the rat forebrain and pituitary gland. I. Characterization of different types of binding sites and their distribution in the Long-Evans strain Neuroscience. 26(1):1988;261-272.
25. Ghaziuddin M., Ghaziuddin N., Stein G.S. Life events and the recurrence of depression. Can. J. Psychiatry. 35:1990;239-242.
26. Gibbs D.M. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinology. 11:1986;131-140.
27. Gillies G.E., Linton E.A., Lowry P.J. Corticotropin-releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 299:1982;355-357.
28. Harbuz M.S., Lightman S.L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 122:1989;705-711.
29. Hauger R.L., Aguilera G. Regulation of corticotropin-releasing hormone receptors and hypothalamic pituitary adrenal axis responsiveness during cold stress. J. Neuroendocrinol. 4:1992;617-624.
30. Hauger R.L., Lorang M., Irwin M., Aguilera G. CRF receptor regulation an sensitization of ACTH responses to acute ether stress during chronic intermittent immobilization stress. Brain Res. 532:1990;34-40.
31. Hauger R.L., Millan M.A., Lorang M., Harwood J.P., Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology. 123:1988;396-405.
32. Herbert J., Forsling M.L., Howes S.R., Stacey P.M., Shiers H.M. Regional expression of c-fos antigen in the basal forebrain following intraventricular infusions of angiotensin and its modulation by drinking either water or saline. Neuroscience. 51(4):1992;867-882.
33. Kiss A., Aguilera G. Regulation of the hypothalamic pituitary adrenal axis during chronic stress: responses to repeated intraperitoneal hypertonic saline injection. Brain Res. 630:1993;262-270.
34. Kovacs G.L., Bohus B., Versteeg D.H.G., De Kloet R. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res. 175:1979;303-314.
35. Kruse H., Van Wimersma Greidanus T.J.B., De Weid D. Barrel rotation induced by vasopressin and related peptides in rats. Pharmacol. Biochem. Behav. 7:1977;311-313.
36. Lebrun C.J., Gruber M.G., Meister M., Unger T. Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat septum. Brain Res. 531:1990;167-172.
37. Lebrun C.J., Rohmeiss P., Demmert G., Unger T. Sensitization to pressor effects by repeated central injections of vasopressin in conscious rats. Brain Res. 505:1989;39-43.
38. Lee Y., López D.E., Meloni E.G., Davis M. A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J. Neurosci. 16(11):1996;3775-3789.
39. Legros J.-J., Ansseau M., Timsit-Berthier M. Neurohypophyseal peptides and psychiatric diseases. Reg. Pept. 45:1993;133-138.
40. Liang K.C., Melia K.R., Miserendino M.J.D., Falls W.A., Campeau S., Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J. Neurosci. 12(6):1992;2303-2312.
41. Lieberman J.A., Kinon B.J., Loebel A.D. Dopaminergic mechanisms on idiopathic and drug-induced psychosis. Schizophr. Bull. 16:1990;97-110.
42. Merchenthaler I. Corticotropin-releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides. 5:1984;53-69.
43. 1-receptor antagonist. Neuropeptides. 23:1992;137-142.
44. Pittman Q.J., Lawrence D., McLean L. Central effects of arginine vasopressin on blood pressure in rats. Endocrinology. 110:1982;1058-1060.
45. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 149:1992;999-1010.
46. Poulin P., Pittman Q.J. Arginine vasopressin (AVP)-induced sensitization in brain: facilitated inositol phosphate production without changes in receptor number. J. Neuroendocrinol. 5:1993;23-31.
47. Poulin P., Szot P., Dorsa D.M., Pittman Q.J. Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors. Eur. J. Pharmacol. 294:1995;29-39.
48. Purba J.S., Hoogendijk W.J.G., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry. 53:1996;137-143.
49. Rivier C., Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology. 113:1983;939-942.
50. Roozendaal B., Schoorlemmer G.H.M., Koolhaas J.M., Bohus B. Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats. Brain Res. Bull. 32:1993;573-579.
51. B.A. Sorg, P.W. Kalivas, Stress and neuronal sensitization, in: M.J. Friedman, D.S. Charney, A.Y. Deutch (Eds.), Neurobiological and Clinical Consequences of Stress: from Normal Adaptation to PTSD, Lippincott-Raven Publishers, Philadelphia, 1995, pp. 83-102.
52. J.D. Stoehr, S.W. Cheng, M.C. Serlin, C.P. Cramer, W.G. North, A physiological role of vasopressin in the expression of conditioned fear, Ann. NY Acad. Sci. (1994) 674-676.
53. S.C. Stout, C.D. Kilts, C.B. Nemeroff, Neuropeptides and stress. Preclinical findings and implications for pathophysiology, in: M.J. Friedman, D.S. Charney, A.Y. Deutch (Eds.), Neurobiological and Clinical Consequences of Stress: from Normal Adaptation to PTSD, Lippincott-Raven Publishers, Philadelphia, 1995, pp. 103-123.
54. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
55. Tribollet E., Barberis C., Jard S., Dubois-Dauphin M., Dreifuss J.J. Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res. 442:1988;105-118.
56. Van Dijken H.H., DeGoeij D.C.E., Sutanto W., Mos J., De Kloet E.R., Tilders F.J.H. Short inescapable stress produces long-lasting changes in the brain-pituitary-adrneal axis of adult male rats. Neuroendocrinology. 58:1993;57-64.
57. F.W. Van Leeuwen, Vasopressin receptors in the brain and pituitary, in: D.M. Gash, G.J. Boer (Eds.), Vasopressin. Principles and Properties, Plenum Press, New York and London, 1983, pp. 477-495.
58. Wang B.C., Share L., Crofton J.T., Kimura T. Changes in vasopressin concentration in plasma and cerebrospinal fluid in response to hemorrhage in anesthetized dogs. Neuroendocrinology. 33:1981;61-66.
59. Winslow J.T., Hastings N., Carter C.S., Harbaugh C.R., Insel T.R. A role for central vasopressin in pair bonding in monogamous prairie voles. Nature. 365:1993;545-548.
60. Wise R.A., Leeb K. Psychomotor-stimulant sensitization: a unitary phenomenon? Behav. Pharmacol. 4:1993;339-349.
61. Wurpel J.N., Dundore R.L., Barbella Y.R., Balaban C.D., Keil L.C., Severs W.B. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology Brain Res. 365:1986;21-29.